COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 147 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,633,715 | -18.8% | 386,296 | -21.9% | 0.02% | -19.0% |
| Q2 2023 | $10,626,289 | -23.6% | 494,476 | -14.7% | 0.02% | -30.0% |
| Q1 2023 | $13,912,065 | +95.3% | 579,911 | +88.9% | 0.03% | +87.5% |
| Q4 2022 | $7,123,096 | +1013.0% | 307,030 | +668.2% | 0.02% | +1500.0% |
| Q3 2022 | $640,000 | +131.0% | 39,965 | +241.1% | 0.00% | 0.0% |
| Q2 2021 | $277,000 | -83.9% | 11,718 | -89.7% | 0.00% | -87.5% |
| Q1 2019 | $1,724,000 | – | 113,922 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |